These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 15661529)
1. DNA tumor viruses -- the spies who lyse us. O'Shea CC Curr Opin Genet Dev; 2005 Feb; 15(1):18-26. PubMed ID: 15661529 [TBL] [Abstract][Full Text] [Related]
2. DNA tumor viruses and human cancer. Damania B Trends Microbiol; 2007 Jan; 15(1):38-44. PubMed ID: 17113775 [TBL] [Abstract][Full Text] [Related]
3. Viruses - seeking and destroying the tumor program. O'Shea CC Oncogene; 2005 Nov; 24(52):7640-55. PubMed ID: 16299526 [TBL] [Abstract][Full Text] [Related]
4. Involvement of PP2A in viral and cellular transformation. Arroyo JD; Hahn WC Oncogene; 2005 Nov; 24(52):7746-55. PubMed ID: 16299534 [TBL] [Abstract][Full Text] [Related]
5. Impact of viral oncogenesis on responses to anti-cancer drugs and irradiation. Efferth T; Grassmann R Crit Rev Oncog; 2000; 11(2):165-87. PubMed ID: 11005511 [TBL] [Abstract][Full Text] [Related]
6. The common mechanisms of transformation by the small DNA tumor viruses: The inactivation of tumor suppressor gene products: p53. Levine AJ Virology; 2009 Feb; 384(2):285-93. PubMed ID: 19081592 [TBL] [Abstract][Full Text] [Related]
7. Tumour virology--history, status and future challenges. Kalland KH; Ke XS; Øyan AM APMIS; 2009 May; 117(5-6):382-99. PubMed ID: 19400863 [TBL] [Abstract][Full Text] [Related]
8. DNA Tumor Viruses and Cell Metabolism. Mushtaq M; Darekar S; Kashuba E Oxid Med Cell Longev; 2016; 2016():6468342. PubMed ID: 27034740 [TBL] [Abstract][Full Text] [Related]
9. Not all viruses are bad guys: the case for reovirus in cancer therapy. Norman KL; Lee PW Drug Discov Today; 2005 Jun; 10(12):847-55. PubMed ID: 15970267 [TBL] [Abstract][Full Text] [Related]
11. Integrating the biological characteristics of oncolytic viruses and immune cells can optimize therapeutic benefits of cell-based delivery. Thorne SH; Contag CH Gene Ther; 2008 May; 15(10):753-8. PubMed ID: 18356814 [TBL] [Abstract][Full Text] [Related]
12. EGFR as a target: rationale for therapy. Wujcik D Semin Oncol Nurs; 2006 Feb; 22(1 Suppl 1):5-9. PubMed ID: 16616281 [TBL] [Abstract][Full Text] [Related]
13. Multiple pathways regulated by the tumor suppressor PP2A in transformation. Westermarck J; Hahn WC Trends Mol Med; 2008 Apr; 14(4):152-60. PubMed ID: 18329957 [TBL] [Abstract][Full Text] [Related]
14. Current status and issues in cancer stem cell study. Yang YM; Chang JW Cancer Invest; 2008 Aug; 26(7):741-55. PubMed ID: 18608212 [TBL] [Abstract][Full Text] [Related]
15. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications. Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893 [TBL] [Abstract][Full Text] [Related]
16. The potential of oncolytic virus therapy for pancreatic cancer. Kasuya H; Takeda S; Nomoto S; Nakao A Cancer Gene Ther; 2005 Sep; 12(9):725-36. PubMed ID: 15818382 [TBL] [Abstract][Full Text] [Related]
17. DNA viruses in human cancer: an integrated overview on fundamental mechanisms of viral carcinogenesis. Elgui de Oliveira D Cancer Lett; 2007 Mar; 247(2):182-96. PubMed ID: 16814460 [TBL] [Abstract][Full Text] [Related]
18. Reovirus - possible therapy of cancer. Figova K; Hrabeta J; Eckschlager T Neoplasma; 2006; 53(6):457-62. PubMed ID: 17167712 [TBL] [Abstract][Full Text] [Related]